Cirrus’ Christmas Countdown Is Here!
The festive season has arrived. Christmas cheer is everywhere as children write their lists to Father Christmas, people flock to the shops and supermarkets brace themselves for one of the busiest periods of the year. With so much to look forward to, it’s obvious that Andy Williams was right: it really is the most wonderful time of the year.
Here at Cirrus Research, we think one of the most exciting things about the festive season is the countdown to the big day, made even sweeter by the promise of a little treat every day as the doors on the Advent calendar are opened.
This year, we’re bringing the joy of Advent to all of our customers and followers on social media.
Every working day on the journey to Christmas, up until the 21st December, we’ll be opening a door on our Advent calendar and giving at least one lucky winner a great prize. Each winner will be chosen completely at random, so you’ll need to make sure that you keep up-to-date with our social media posts and emails to check if you’ve won!
We’ll also be running a weekly #FestiveFriday raffle for our followers on social media. You can increase your chance of winning a prize in our raffle by interacting with our #CirrusAdvent posts on social media:
- Each like on that week’s posts will get you one entry into our Advent raffle
- Each comment/reply on that week’s posts will get you two entries into our Advent raffle
- Each share/retweet on that week’s posts will get you three entries into our Advent raffle
- If you do all three on every post in that week, you’ll get 35 entries into our raffle!
You’ve got nothing to lose but lots to win!
Let’s get the festivities started and crack on with Cirrus’ Christmas Countdown!
The #FestiveFriday raffle has now closed for this year – thanks to everyone who interacted with us!
Our #FestiveFriday raffle winners:
- Alison Oswald
- Ian Wiltshire
- Ross Valentine
Want to know who’s been behind the doors on our calendar? Check out our previous winners below!
- Monday 3rd December – Triumph Motorcycles
- Tuesday 4th December – OHD
- Wednesday 5th December – ESS SafeForce
- Thursday 6th December – Scarborough Borough Council
- Friday 7th December – London Sinfonietta
- Monday 10th December – Virgin Atlantic
- Tuesday 11th December – Scantec Industries NV
- Wednesday 12th December – Mercedes AMG
- Thursday 13th December – University Hospital Southampton
- Friday 14th December – Jacobs
- Monday 17th December – Casper BV
- Tuesday 18th December – EGS Solutions
- Wednesday 19th December – AES Solutions
- Thursday 20th December – Ensscom
-
Most popular related searches
Related news
-
The Newly Developed Metabolomics Platform Brings New Insights into Enteroaggregative E. coli
With years of experience in metabolomics services, Creative Proteomics has developed a microbial metabolome analysis platform dedicated to providing high-quality, personalized microbial metabolomics services and reliable data support to clients worldwide. Microorganisms have existed on Earth for at least 3.8 billion years and are found in almost all corners of the biosphere. The diversity of microbial metabolic capabilities and metabolic forms is unmatched by any other organism on Earth. There are approximately...
-
Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease
For children and adolescents with chronic kidney disease (CKD), as for adults, the unmet need is high for new treatments to delay disease progression and preserve kidney function / The Phase III study FIONA will investigate the effect of finerenone in pediatric patients with CKD and severely increased proteinuria Bayer announced today the initiation of the FIONA study, a multicenter, randomized, double-blind, placebo-controlled Phase III study, to investigate the efficacy, safety and pharmacokinetics/pharmacodynam...
-
Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology
To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for clinical research programs that leverage NGS in solid tumors and hematology-oncology applications. The Oncomine Clinical Research Grant awards independent clinical research proposals with up to $200,000 in reagents and general funding. Applications are reviewed for...
-
Flat Medical announced FDA 510(k) clearance of EpiFaith, the Epidural Safety Solution
Flat Medical Co., Ltd., the medtech company specializing in clinical safety solutions, announced it received 510(k) clearance from the U.S. Food and Drug Administration for its EpiFaith® syringe to deliver safe epidural locating solution. Based on the LOR technique, the EpiFaith® syringe is a physician-centered safeguard for epidural analgesia, which is indicated for painless labor, surgical anesthesia and chronic pain management. Compared with traditional practice that relies on the manual sense, EpiFaith&...
-
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies
RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan’s Ministry of Health, Labour, and Welfare (MHLW) for approval to manufacture the Company’s RCT-01 cell therapy for chronic tendinopathy and RCS-01 cell therapy for aging and sun-damaged skin for its upcoming clinical studies. With successful...
Customer comments
No comments were found for Cirrus’ Christmas Countdown Is Here!. Be the first to comment!